• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Expert Insights on NSCLC: Unmet Needs and Innovations from ASCO 2024

Opinion
Video

Jason Porter, MD, outlines the most significant unaddressed challenges in treating and managing non-small cell lung cancer as the field approaches the American Society of Clinical Oncology's 2024 annual meeting.

Related Videos
An expert featured in this series.
An expert featured in this series.
Dr Marco Del Riccio
Related Content
Penicillin | Image Credit: Zerbor - stock.adobe.com

Misalignment Between EHR Penicillin Allergy Flags, Allergist Assessments Signals Need for Improved Documentation

January 8th 2026
Article

EHR penicillin allergy flags do not often match allergist assessments, highlighting the need for improved evaluation processes.

Read More

managed care cast logo

Switching From MA to TM Increases Mental Health Care Use: Angela Liu, PhD, MPH

December 23rd 2025
Podcast

Angela Liu, PhD, MPH, speaks about her study that examined mental health care use by Medicare beneficiaries before and after switching from MA to TM.

Listen

β-blockers were not associated with improved outcomes in patients with acute MI and preserved LVEF, according to a new meta-analysis published in JAMA Cardiology. | Image Credit: @Elena_stock.adobe.com.jpg

β-Blockers Show No Added Benefit After MI With Preserved LVEF

January 7th 2026
Article

A meta-analysis found β-blockers did not improve clinical outcomes in patients with acute MI and preserved LVEF, raising questions about routine use.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

November 25th 2025
Podcast

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

Nimbus Therapeutics and Eli Lilly announced their partnership to develop a novel oral drug for patients with obesity and other metabolic diseases. | Image credit: ARMMY PICCA_AdobeStock.jpeg

Nimbus Therapeutics, Eli Lilly Partner to Develop Novel Oral Metabolic Drug

January 6th 2026
Article

Nimbus Therapeutics and Eli Lilly announce their partnership to develop a novel oral drug for patients with obesity and other metabolic disorders.

Read More

Carlos Doti, MD | Image: AstraZeneca

‘Our Responsibility Should Be to Give You the Closest Thing to a Normal Life’

January 2nd 2026
Article

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.